Consumers May Benefit From Drug Antitrust Case
HELENA – Patients who took the medication Cardizem CD or its generic equivalents between 1998 and early 2003 may be entitled to reimbursement from the proposed settlement of an antitrust case. The deadline to file claims related to the case is Sept. 23.
The approximately $21 million fund is part of a settlement of an antitrust lawsuit brought by the attorneys general of all 50 states, Puerto Rico and the District of Columbia. The case alleges that the makers of the drugs violated antitrust laws and overcharged consumers purchasing Cardizem CD and its generic equivalents.
Consumers who purchased Cardizem CD or any of its AB3-rated generic equivalents from Jan. 1, 1998 through Jan. 29, 2003 may file a claim for recovery. Claim registrations and complete information are available by calling 1-800-372-2406.
The drugs are used to treat hypertension and angina. Hypertension, or high blood pressure, affects as many as 50 million American adults.
The defendants in the case have denied any wrongdoing or liability. The proposed settlement is subject to court review. The settlement also includes funds for third-party payers, governmental purchasers, litigation costs and fees, and the costs related to publicizing and administering the settlement.